Ryan P. O'Quinn, Ph.D.

Ryan’s practice covers a range of technologies, including pharmaceuticals, biotechnology, immunotherapy, medical devices, computer software, business methods, vending technologies, and mechanical systems. In 2024, he was shortlisted for Patent Strategy Attorney of the Year (DC Metro) by LMG Life Sciences. Ryan is recognized in the 2026 edition of Best Lawyers (Biotechnology and Life Sciences Practice). 

Ryan leads the firm’s military veteran’s pro bono programs, and has successfully represented, including as lead counsel, over a dozen disabled veterans before the U.S. Court of Appeals for Veterans Claims. He also serves as a member of the Friends Board of the Legal Services of Northern Virginia.

Prior to joining Finnegan, Ryan conducted doctoral and undergraduate research in cellular and molecular biology and biomedical engineering. His research, including work at the National Institutes of Health (NIH) and the Marine Biological Laboratory at Woods Hole, focused on advanced microscopy techniques and molecular mechanisms regulating cell division. Ryan previously served as an adjunct professor at George Washington University Law School in the Scholarly Writing Program, where he supervised student members of the Federal Circuit Bar Journal. He has participated as a panel advisor during the Pitch Rounds competition of the Southeast BIO (SEBIO) Annual Life Sciences Venture Capital Conference. Ryan also served as an advisor to the Southeast Life Sciences (SLSA) ADVANSE Virtual Pitch Rounds competition which featured early-stage life sciences companies developing solutions related to COVID-19.